Aerothricins: a new class of β-glucan inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 2, 2002-02 ,pp. : 315-318

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Chemotherapy of Human Fungal Diseases. Emphasis on 1,3-&bgr;-Glucan Synthase and Chitin Synthase Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 38, 2013-12 ,pp. : 4859-4887

Bentham Science Publishers

Access to resources Recommend Favorite

1,3-beta-Glucan Synthase: A Useful Target for Antifungal Drugs

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 159-169

Bentham Science Publishers

Access to resources Recommend Favorite

Physiochemical Characterization of β-glucan and in vitro Release of Lactoferrin from β-glucan Microparticles

By  

Current Drug Delivery, Vol. 10, Iss. 6, 2013-01 ,pp. : 713-721

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery

By Jacobs Simone   Bunt Craig R.   Wu Zimei   Lehr Claus-Michael   Rupenthal Ilva D.  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 11, 2012-11 ,pp. : 1337-1343

Informa Healthcare

Access to resources Recommend Favorite